Depression. Depressive disorder
Conditions
Interventions
Intervention 1: Oral mint capsule, 100 mg, once daily for two month. Intervention 2: Oral mint capsule, 10 mg, once daily for two month. Intervention 3: Oral mint capsule, 50 mg, once daily for two mo
Treatment - Drugs
Placebo
Oral mint capsule, 100 mg, once daily for two month
Oral mint capsule, 10 mg, once daily for two month
Oral mint capsule, 50 mg, once daily for two month
Oral mint capsule, 200 mg, once daily for two month
Placebo oral capsule, once daily for two month
Sponsors
Vice-chancellor for Research
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 18-60 years, having depressive symptoms for at least two weeks, having a similar treatment except extract Mentha Pipperita Exclusion criteria: Other psychological disorder, history of admission in psychiatry ward, receiving treatment by ECT (electroconvulsive therapy), history of using any drug except antidepressant drug by psychiatrist in this research
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of depression. Timepoint: Baseline and 2 months after intervention. Method of measurement: Beck Depression Inventory (BDI) and psychiatry interview by DSM IV-TR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazir Hashemi Mohammad Abad
Yasouj University of Medical Sciences
Outcome results
None listed